Anti–CD20 Antibody Therapy and Infection Risk in Demyelinating Diseases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-CD20 Antibody Therapy and Risk of Infection in Patients With Demyelinating Diseases
Mult Scler Relat Disord 2021 Jul 01;52(xx)102988, NR Oksbjerg, SD Nielsen, M Blinkenberg, M Magyari, F SellebjergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.